Pengkun Wei
Overview
Explore the profile of Pengkun Wei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
37
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao T, Wei P, Zhang C, Zhou S, Liang L, Guo S, et al.
Elife
. 2024 Mar;
12.
PMID: 38441416
Radiation therapy is a primary treatment for hepatocellular carcinoma (HCC), but its effectiveness can be diminished by various factors. The over-expression of PD-L1 has been identified as a critical reason...
2.
Wang M, Li Y, Lv Y, Tang J, Wei P, Lu P, et al.
J Hazard Mater
. 2023 Dec;
465:133353.
PMID: 38154186
To comprehensively characterize residents' exposure to major semi-volatile organic compounds (SVOCs), samples of indoor floor wipes, size-segregated airborne particles, gaseous air, food, and paired skin wipes were simultaneously collected from...
3.
Shi S, Feng Q, Zhang J, Wang X, Zhao L, Fan Y, et al.
Sci Total Environ
. 2023 Dec;
912:169393.
PMID: 38104845
To fill the knowledge gaps regarding the global patterns of human exposure to flame retardants (FRs) (i.e., brominated flame retardants (BFRs) and organophosphorus flame retardants (OPFRs)), data on the levels...
4.
Wang X, Li R, Luo X, Mu J, Peng J, Yan G, et al.
J Colloid Interface Sci
. 2023 Oct;
654(Pt A):454-465.
PMID: 37857098
Enhancing low-temperature activity is a focus for carbon monoxide (CO) elimination by catalytic oxidation. In this work, the hierarchical flower-like silver (Ag) modified cobalt oxides (CoO) nanosheets were prepared by...
5.
Jia H, Wei P, Zhou S, Hu Y, Zhang C, Liang L, et al.
Cell Death Discov
. 2023 Aug;
9(1):318.
PMID: 37640735
Hepatocellular carcinoma (HCC), the most prevalent type of aggressive liver cancer, accounts for the majority of liver cancer diagnoses and fatalities. Despite recent advancements in HCC treatment, it remains one...
6.
Li N, Zhang J, Yu H, Xu M, Feng Q, Zhang J, et al.
Environ Geochem Health
. 2023 Jun;
45(8):6199-6214.
PMID: 37273087
An accurate assessment of human exposure to pollutants through the ingestion of dust and/or soil particles depends on a thorough understanding their rate of human ingestion. To this end, we...
7.
Wang M, Lv Y, Lv X, Wang Q, Li Y, Lu P, et al.
Chemosphere
. 2022 Dec;
313:137595.
PMID: 36563718
The potential effects of heavy metals on human health have attracted increasing attention as most people spend up to 90% of their time indoors. Human exposure to heavy metals in...
8.
Wei P, Jia H, Li R, Zhang C, Guo S, Wei S, et al.
Cell Biol Int
. 2022 Oct;
47(2):439-450.
PMID: 36259746
A colon tumor, one of the digestive tract malignant tumors, is harmful to human health. A potential new treatment still deserves attention. The development of a new drug needs more...
9.
Chen P, Li Y, Wei P, Liang L, Li B, Cao Y, et al.
Int Immunopharmacol
. 2022 Aug;
111:109127.
PMID: 35964407
Hepatocellular carcinoma (HCC) is a primary liver cancer representing serious harm to human health. The effective treatment of HCC is challenging. Lenvatinib is an inhibitor of polytyrosine kinase that exerts...
10.
Ren F, Zhang Y, Qin Y, Shang J, Wang Y, Wei P, et al.
Cell Death Discov
. 2022 May;
8(1):264.
PMID: 35577774
Hepatocellular carcinoma (HCC) is a common digestive malignant tumor with high morbidity and mortality worldwide, however, the treatment of HCC and prognosis of patients are not optimistic, finding more effective...